Antiplatelet therapy after successful percutaneous coronary intervention for chronically occluded coronary artery: A prospective, multicentre, randomized study comparing two durations of dual antiplatelet therapy
Phase 1
- Conditions
- chronically occluded coronary arteryTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Registration Number
- CTIS2023-508148-23-01
- Lead Sponsor
- Assistance Publique Hopitaux De Marseille
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 660
Inclusion Criteria
Patients who underwent a successful coronary stent implantation for chronic coronary occlusion, eligible for long-term aspirin therapy and requiring a dual antiplatelet therapy, Affiliated to Social Security system, Signature of informed consent, Age > 18 years old
Exclusion Criteria
Dual antiplatelet therapy contra-indication, Patient with hypersensitivity to aspirin (or any of its excipients) and/or to any of the active substance or to any of the excipients of the investigational medical product used in this study (clopidogrel), Patient with contraindication to aspirin and/or clopidogrel, No coronary stent implanted, Age<18years, Patient under guardianship, Pregnancy or breast feeding, Prasugrel or ticagrelor use
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method